The Cell and Tissue Imaging Core provides advanced cell and tissue imaging technology, services, and scientific consultation. The Core facilitates scientific collaboration and advances the ability of USC Norris members to conduct innovative cancer research. Since its founding 15 years ago, the Cell and Tissue Imaging Core has been continuously approved and funded by the NCI CCSG. The facility has been ably led by the founding Director, Dr. David Hinton, and supervised by Technical Director, Ernesto Barron, both of whom have over 30 years of experience in the field of microscopy. In 2014, Dr. Scott Fraser, an internationally recognized innovator in imaging technology, was recruited to USC from Caltech. With the goal of providing national leadership in imaging technology through the facility, Dr. Fraser joined Dr. Hinton as Co-Director effective January 2015. The Cell and Tissue Imaging Core makes it possible for Cancer Center members to easily access a wide range of sophisticated imaging equipment and services, including laser scanning confocal/multiphoton microscopy, live cell spinning disk confocal imaging, transmission electron microscopy (TEM), scanning electron microscopy (SEM), digital light and fluorescence microscopy, fluorescence and bright field laser capture microdissection, thin sectioning, cryo-sectioning and embedding techniques, and computer aided graphics. In its effort to provide state-of-the-art technology, the Core is adding new instrumentation: a STORM super-resolution single-molecule imaging fluorescence microscope, a Two-Photon SPIM light sheet imager, a Flip Trap imaging scope, and a novel Hyperspectral Phasor Imaging (HPI) instrument. As a part of its mission to help members learn how Core resources can advance their research, the Core has an active education and training program through which it advises and instructs USC Norris investigators in novel methodologies and protocols to enhance their cell and tissue imaging capability. In FY 2013-2014, the Core was used by 36 Cancer Center members from six USC Norris Research Programs, which reflects both the quality of the service and the value of continued education and training efforts. In the fall of 2015, the Core will relocate to renovated space in USC Norris Topping Tower. Closer proximity to the majority of users and increased overall visibility should result in increased usage in the next project period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-44
Application #
9607929
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
2018-12-01
Project End
2020-11-30
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
44
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Ricker, Charité N; Koff, Rachel B; Qu, Chenxu et al. (2018) Patient communication of cancer genetic test results in a diverse population. Transl Behav Med 8:85-94
Valentin-Torres, Alice; Savarin, Carine; Barnett, Joslyn et al. (2018) Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. J Neuroinflammation 15:121
Tobin, Jessica; Miller, Kimberly A; Baezconde-Garbanati, Lourdes et al. (2018) Acculturation, Mental Health, and Quality of Life among Hispanic Childhood Cancer Survivors: A Latent Class Analysis. Ethn Dis 28:55-60
Jayne, Jordanna G; Bensman, Timothy J; Schaal, Justin B et al. (2018) Rhesus ?-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment. Am J Respir Cell Mol Biol 58:310-319
Lee, Brian H; Stallcup, Michael R (2018) Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5. PLoS One 13:e0196965
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Woodham, Andrew W; Cheloha, Ross W; Ling, Jingjing et al. (2018) Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunol Res 6:870-880
Matsusaka, S; Wu, A H; Cao, S et al. (2018) Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Pharmacogenomics J 18:262-269
Vannini, Ivan; Fanini, Francesca; Fabbri, Muller (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128-133
Veyseh, Maedah; Ricker, Charite; Espenschied, Carin et al. (2018) Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature. Front Oncol 8:259

Showing the most recent 10 out of 842 publications